Highlights and Quick Summary
- Long Term Debt (Total) for the quarter ending December 31, 2022 was $422 Thousand (a -14.05% decrease compared to previous quarter)
- Year-over-year quarterly Long Term Debt (Total) decreased by -33.54%
- Annual Long Term Debt (Total) for 2022 was $559 Thousand (a 0.0% decrease from previous year)
- Annual Long Term Debt (Total) for 2022 was $559 Thousand (a 162.44% increase from previous year)
- Annual Long Term Debt (Total) for 2020 was $213 Thousand (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long Term Debt (Total) of Benitec Biopharma Limited
Most recent Long Term Debt (Total)of BNTC including historical data for past 10 years.Interactive Chart of Long Term Debt (Total) of Benitec Biopharma Limited
Benitec Biopharma Limited Long Term Debt (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $0.42 | $0.49 | $0.56 | $0.64 | $0.56 |
2021 | – | $0.7 | $0.76 | $0.05 | – |
2020 | $0.11 | $0.16 | $0.21 | $0.26 | $0.21 |
2019 | $0.32 | – | – | – | – |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology